RSV vaccines recommended for adults 65 and up in important regulatory milestone. ... Respiratory syncytial virus infects nearly everyone by age 2 and typically causes cold symptoms.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the ...

The CDC recommends that everyone 6 months and older gets a flu vaccine every year, including those 50 and up. ... "Together with flu and RSV, ... which called for vaccines in adults 65 and older.

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults ages 18 to 59 who are at high risk of severe illness if they ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

In the 2024 Australian winter period, RSV laboratory-notified cases in adults aged 65 and older were nearly two-thirds the number of influenza cases in the same age group. 2 90% of RSV-related ...

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company said Saturday, the first approval under new regulations.

In the 2024 Australian winter period, RSV laboratory-notified cases in adults aged 65 and older were nearly two-thirds the number of influenza cases in the same age group.2 90% of RSV-related ...

By Chandni Shah, Mariam Sunny and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the ...